Ad is loading...
TRVLX
Price
$50.27
Change
-$0.27 (-0.53%)
Updated
Nov 15 closing price
VIVIX
Price
$68.70
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

TRVLX vs VIVIX

Header iconTRVLX vs VIVIX Comparison
Open Charts TRVLX vs VIVIXBanner chart's image
T. Rowe Price Value
Price$50.27
Change-$0.27 (-0.53%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.70
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
TRVLX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TRVLX vs. VIVIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRVLX is a Buy and VIVIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. TRVLX (31.3B). VIVIX pays higher dividends than TRVLX: VIVIX (2.37) vs TRVLX (1.17). TRVLX was incepted earlier than VIVIX: TRVLX (30 years) vs VIVIX (26 years). TRVLX is a more actively managed with annual turnover of: 62.30 vs. VIVIX (10.00). TRVLX has a lower initial minimum investment than VIVIX: TRVLX (2500) vs VIVIX (5000000). TRVLX (26.17) and VIVIX (25.54) have marching annual gain over last year. VIVIX return over 5 years is better than : 50.79 vs. TRVLX (40.50).
TRVLXVIVIXTRVLX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years26 years-
Gain YTD19.86217.922111%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets31.3B184B17%
Annual Yield % from dividends1.172.3749%
Returns for 1 year26.1725.54102%
Returns for 3 years-1.6021.57-7%
Returns for 5 years40.5050.7980%
Returns for 10 years46.21110.5042%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXR164.561.13
+0.69%
Extra Space Storage
PALT1.83N/A
N/A
Paltalk
AOMR9.80-0.06
-0.61%
Angel Oak Mortgage REIT
DLO9.89-0.31
-3.04%
DLocal Limited
GYRE13.12-0.72
-5.20%
Gyre Therapeutics